Consolidated Statement of Cash Flows

IR

Consolidated Statement of Cash Flows

(Million yen)

 
FY2021
(as of December 31,
2021)
FY2022
(as of December 31,
2022)
Cash flows from operating activities  
 
Profit before income taxes 7,606 9,922
Depreciation 219 228
Amortization of goodwill 207 164
Increase (decrease) in allowance
for doubtful accounts 
(43) 31
Increase (decrease) in provision for
bonuses
37 125
Increase
(decrease) in
allowance for
subscription
cancellations
(24)
Interest and dividend income (3) (3)
Interest expenses 7 7
Share of loss (profit) of entities
accounted for using equity method
(26) (64)
Loss on retirement of non-current assets 22 25
Loss (gain) on sale of investment
securities
(20) (69)
Loss (gain) on valuation 
investment securities
0
Loss on COVID-19 37 22
Decrease (increase) in trade receivables (1,414) (1,771)
Decrease (increase) in inventories 3 (17)
Decrease (increase) in accounts receivable-other 85 (8)
Increase (decrease) in trade payables 341 310
Increase (decrease) in
accrued expenses
301 330
Increase (decrease) in
accrued consumption taxes
519 395
Increase (decrease) in accrued
enterprise taxes
38 37
Increase (decrease) in
retirement benefit liability
56 68
Other, net 49 214
Subtotal 7,996 9,946
Interest and dividends 
received
45 3
Interest 
paid
(7) (7)
Payment of loss on COVID-19 (34) (21)
Income taxes paid (1,639) (3,126)
Income taxes refund 7 1
Net cash provided by (used in) operating
activities
6,368 6,796

(Million yen)

 
FY2021
(as of December 31,
2021)
FY2022
(as of December 31,
2022)
Cash flows from investing activities  
 
Purchase of property,
plant and equipment
(52) (103)
Purchase of intangible assets (127) (181)
Proceeds from sales of investment
securities
20 186
Purchase of shares of subsidiaries
resulting in change in scope of
consolidation
(844)
Proceeds from collection of
loans receivable
45 6
Other, net 14 (22)
Net cash provided by (used in) investing
activities
(99) (958)
Cash flows from financing activities  
 
Repayments of short-term borrowings (80)
Repayments of long-term borrowings (46)
Purchase of treasury shares (554) (907)
Dividends paid (1,571) (1,667)
Other, net 37 (2)
Net cash provided by (used in) financing
activities
(2,168) (2,622)
Effect of exchange rate change on cash and cash equivalents 0
Net increase (decrease)
in cash and cash equivalents
4,101 3,216
Cash and cash equivalents
at beginning of period
13,309 17,410
Cash and cash equivalents
at end of period
17,410 20,626

ARCHIVE